Skip to main navigation Skip to search Skip to main content

New Acute Kidney Injury Findings from Gwangju Institute of Science and Technology (GIST) Outlined (Levan-stabilized Prussian blue nanoparticles targeting the CD44 receptor for the effective treatment of acute kidney injury)

Press/Media

Period2025.12.30

Media coverage

1

Media coverage

  • TitleNew Acute Kidney Injury Findings from Gwangju Institute of Science and Technology (GIST) Outlined (Levan-stabilized Prussian blue nanoparticles targeting the CD44 receptor for the effective treatment of acute kidney injury)
    Media name/outletSouth Korea Daily Report
    Country/TerritoryUnited States
    Date25.12.30
    PersonsWon-Il Choi
View all 1
View less